Aerovate Therapeutics Inc (AVTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Operating Expenses | 24,618 | 22,066 | 21,368 | 20,336 | 17,639 |
Operating Income | -24,618 | -22,066 | -21,368 | -20,336 | -17,639 |
Other Income | 1,432 | 1,709 | 1,805 | 1,311 | 1,119 |
Pre-tax Income | -23,186 | -20,357 | -19,563 | -19,025 | -16,520 |
Net Income Continuous | -23,186 | -20,413 | -19,563 | -19,025 | -16,520 |
Net Income | $-23,186 | $-20,413 | $-19,563 | $-19,025 | $-16,520 |
EPS Basic Total Ops | -0.83 | -0.73 | -0.71 | -0.76 | -0.67 |
EPS Basic Continuous Ops | -0.83 | -0.74 | -0.71 | -0.76 | -0.67 |
EPS Diluted Total Ops | -0.83 | -0.73 | -0.71 | -0.76 | -0.67 |
EPS Diluted Continuous Ops | -0.83 | -0.74 | -0.71 | -0.76 | -0.67 |
EPS Diluted Before Non-Recurring Items | N/A | -0.74 | -0.71 | -0.76 | -0.67 |
EBITDA(a) | $-25,349 | $-22,977 | $-22,151 | $-20,953 | $-18,289 |